Related Experiment Videos
Probable involvement of a glycoconjugate in IMR-32 DNA synthesis: decrease of DNA polymerase alpha 2 activity after
Summary
Tunicamycin treatment alters DNA polymerase alpha 2 activity in neuroblastoma cells, reducing its sensitivity to ricin 1B inhibition. This suggests a role for carbohydrate modifications in enzyme function.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- DNA polymerase alpha is crucial for DNA replication.
- Tunicamycin is known to inhibit N-linked glycosylation.
- Neuroblastoma cells provide a model for studying cellular processes.
Purpose of the Study:
- To investigate the effect of tunicamycin on DNA polymerase alpha activity.
- To determine the impact of tunicamycin treatment on DNA polymerase alpha 2 inhibition by ricin 1B.
- To explore potential structural changes in DNA polymerase alpha 2.
Main Methods:
- DEAE-cellulose column chromatography for enzyme separation.
- Tunicamycin treatment of IMR-32 neuroblastoma cells.
- Inhibition assays using ricin 1B.
- Heat inactivation studies at 50°C.
Main Results:
- Tunicamycin treatment reduced DNA polymerase alpha 2 activity by 40-60%.
- DNA polymerase alpha 2 from treated cells became insensitive to ricin 1B inhibition.
- Heat inactivation profiles differed significantly between treated and untreated enzyme forms.
Conclusions:
- Tunicamycin-induced changes affect DNA polymerase alpha 2 activity and inhibitor sensitivity.
- A beta-linked galactose-containing carbohydrate chain may be involved in the catalytic subunit.
- These findings suggest post-translational modifications influence DNA polymerase alpha 2 function.